NACDS: Medication management is key measurement for exchange health plans January 23, 2014 | By Antoinette Alexander ARLINGTON, Va. — When selecting an exchange health plan under the Affordable Care Act, consumers should be able to evaluate plans’ success in medication management, among other quality measures, the National Association of Chain Drug Stores stated in […]
New and Generic Drug Approvals January 23, 2014 The FDA has released a New and Generic Drug Approvals list. To view this list, click here:
Mylan Launches Generic Prandin® Tablets January 23, 2014 Displayed with permission from PR Newswire PITTSBURGH, Jan. 23, 2014 /PRNewswire/ — Mylan Inc. (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Repaglinide Tablets, 0.5 mg, 1 mg and 2 mg. This product is the generic version of Novo Nordisk’s Prandin ®, […]
Ranbaxy receives US FDA Form 483 at Indian API plant By Dan Stanton+, 13-Jan-2014 An Indian API facility has received a form 483 from the US FDA in the latest setback for troubled drugmaker Ranbaxy. http://www.in-pharmatechnologist.com/Ingredients/Ranbaxy-receives-US-FDA-Form-483-at-Indian-API-plant
Trxade Health, Inc. (NASDAQ: MEDS)